logo

AEMD

Aethlon Medical·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

AEMD fundamentals

Aethlon Medical (AEMD) released its earnings on Nov 12, 2025: revenue was 0 (YoY 0.00%), beat estimates; EPS was -3.74 (YoY -1770.00%), missed estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-3.74
-1770.00%
Report date
Nov 12, 2025
AEMD Earnings Call Summary for Q2,2026
  • Clinical Progress: Cohort 1 showed promising EV reductions and T cell improvements; Cohort 2 targeting one patient/month with enhanced recruitment strategies.
  • Financial Strength: 48% YoY expense reduction to $1.5 million, with $5.8 million cash balance supporting operations.
  • Innovation Focus: Long COVID EV research nearing publication, and simplified Hemopurifier system under development.
  • Upcoming Milestones: Cohort 2 interim data expected in Q1 2026, with Q3 2026 earnings release in February.
EPS
Revenue

Revenue & Expenses

Key Indicators

Aethlon Medical (AEMD) key financial stats and ratios, covering profitability, financial health, and leverage.
Aethlon Medical (AEMD)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Aethlon Medical (AEMD)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Aethlon Medical (AEMD)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Aethlon Medical (AEMD) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Aethlon Medical (AEMD) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield